Meeting
2023 ASCO Annual Meeting
AOST2031: An in-progress COG phase 3 randomized controlled trial comparing open vs thoracoscopic management of pulmonary metastases in patients with osteosarcoma.
Authors
John J Doski
University of Texas Health Sciences Center at San Antonio, San Antonio, TX
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Bone Tumors
Clinical Trial Registration Number
NCTN05235165
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr TPS11579)
DOI
10.1200/JCO.2023.41.16_suppl.TPS11579
Abstract #
TPS11579
Poster Bd #
513a
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Spine high-grade osteosarcoma in the era of radiotherapy with high-energy charged particles: A single institution retrospective analysis.
First Author: Gisberto Evangelisti
Poster
2014 ASCO Annual Meeting
Results of a randomized prospective clinical trial evaluating maintenance chemotherapy in patients with high-grade, operable osteosarcoma: A report from the Latin American Group of Osteosarcoma Treatment.
First Author: Antonio Sergio Petrilli Sr.
Poster
2012 ASCO Annual Meeting
EURAMOS-1 study: Recruitment, characteristics, and initial treatment of more than 2,000 patients (pts) with high-grade osteosarcoma.
First Author: Jeremy Whelan
Poster
2024 ASCO Annual Meeting
Harmonizing cancer care delivery for AYAs with osteosarcoma: Comparison of pediatric and medical oncology approaches in a single center.
First Author: Ariel Nash